Novavax CEO Rahul Singhvi – An Interview With “The Pink Sheet” DAILY, Part 2 of 3
This article was originally published in The Pink Sheet Daily
Executive Summary
Novavax execs describe the firm's Virus Like Particle technology and how disposable, egg-less virus manufacturing is changing the industry.
You may also be interested in...
Novavax CEO Rahul Singhvi – An Interview With “The Pink Sheet” DAILY, Part 3 of 3
Novavax execs discuss alternatives to injectable vaccines and how the vaccine industry is changing.
Novavax CEO Rahul Singhvi – An Interview With “The Pink Sheet” DAILY, Part 3 of 3
Novavax execs discuss alternatives to injectable vaccines and how the vaccine industry is changing.
Novavax CEO Rahul Singhvi - An Interview With “The Pink Sheet” DAILY
Vaccine firm tells "The Pink Sheet" DAILY about its virus-like particles process for making vaccines and how its processes can be less expensive and require smaller facilities.